Published in Clin Chem on February 01, 1998
Overview of therapeutic drug monitoring. Korean J Intern Med (2009) 0.94
Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83
Fundament and Prerequisites for the Application of an Antifungal TDM Service. Curr Fungal Infect Rep (2015) 0.80
Identification and prevention of antiepileptic drug noncompliance: the collaborative use of state-supplied pharmaceutical data. ISRN Pediatr (2014) 0.76
Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci (1998) 2.68
Evaluation of blood culture procedures in a pediatric hospital. J Clin Microbiol (1979) 2.59
Overnight orthokeratology. Optom Vis Sci (2000) 2.27
Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye (2007) 2.05
Rigid contact lens fitting relationships in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Optom Vis Sci (1999) 1.53
Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Cornea (1996) 1.46
Transient rigid lens-induced striae in keratoconus. Optom Vis Sci (1993) 1.39
Corneal scarring and vision in keratoconus: a baseline report from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea (2000) 1.05
Central and peripheral corneal thickness in keratoconus and normal patient groups. Optom Vis Sci (1994) 0.98
Standardized rigid contact lens fitting protocol for keratoconus. Optom Vis Sci (1996) 0.92
Keratoconus. Optom Clin (1995) 0.88
Economic and outcome issues for therapeutic drug monitoring in medicine. Ther Drug Monit (1998) 0.86
A summary of the findings from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. CLEK Study Group. Optometry (2001) 0.82
Bayesian approaches in pharmacokinetic decision making. Clin Pharm (1984) 0.81
Characteristics of corneal staining in hydrogel contact lens wearers. Optom Vis Sci (1996) 0.79
Feasibility of fitting contact lenses with apical clearance in keratoconus. Optom Vis Sci (1996) 0.79
Corneal thickness changes with extended contact lens wear. Am J Optom Physiol Opt (1980) 0.79
The calculation and use of carcinogenic potency: a review. Regul Toxicol Pharmacol (1985) 0.78
Using population-based serum drug concentration cutoff values to predict toxicity: test performance and limitations compared with Bayesian interpretation. Clin Pharm (1990) 0.78
Quality laboratory service and cost containment: are the two incompatible. Am J Med Technol (1979) 0.76
Rigid lens-induced striae. Optom Vis Sci (1993) 0.75
Bayesian and threshold probabilities in therapeutic drug monitoring: when can serum drug concentrations alter clinical decisions? Am J Hosp Pharm (1994) 0.75
Therapeutic drug monitoring: do the improved outcomes justify the costs? Clin Pharmacokinet (2001) 0.75
What is the risk? Risk Anal (1991) 0.75
Is O-K okay? Optom Vis Sci (1998) 0.75
A priori considerations when using laboratory determinations in cost-effectiveness and clinical decision analyses. Am J Med Technol (1981) 0.75
Crazing in a rigid gas permeable contact lens. CLAO J (1988) 0.75
Rodent carcinogenicity testing. Fundam Appl Toxicol (1986) 0.75
Corneal response and vision with the Softperm lens in simulated aircraft conditions. J Am Optom Assoc (1996) 0.75
Effect of topical anesthetic use on initial patient satisfaction and overall success with rigid gas permeable contact lenses. Optom Vis Sci (1998) 0.75
Measured and laboratory-stated parameters of hydrophilic contact lenses. Am J Optom Physiol Opt (1977) 0.75
Comparing nonphysician and physician laboratory administrative responsibilities. Am J Med Technol (1983) 0.75
Academic affiliation of medical laboratory science and pharmacy programs: Advantages for growth and recognition. Am J Med Technol (1981) 0.75
Test performance characteristics of the serum phenytoin concentration (SPC): the relationship between SPC and patient response. The Veterans Administration Epilepsy Cooperative Study Group. Ther Drug Monit (1991) 0.75
Corneal endothelial response to rigid contact lenses. Am J Optom Physiol Opt (1980) 0.75
Flatter than "K," on "K," steeper than "K": does the cornea know the difference? Am J Optom Physiol Opt (1981) 0.75
Corneal endothelial observation techniques. Am J Optom Physiol Opt (1981) 0.75
Use of a clinical data registry to evaluate medical technologies. Experience from the International Bone Marrow Transplant Registry. Int J Technol Assess Health Care (1991) 0.75
A ladder curriculum in clinical microbiology. Am J Med Technol (1979) 0.75
Applying decision analysis in therapeutic drug monitoring: using receiver-operating characteristic curves in comparative evaluations. Clin Pharm (1986) 0.75
A comparison of two methods of evaluating cornea-to-contact lens base curve fluorescein patterns in keratoconus. Optom Vis Sci (2001) 0.75
Making serum drug levels more meaningful. Ther Drug Monit (1989) 0.75
Increasing severity of illness among patients undergoing phase 1 trials. Implications for nursing resources. Cancer Nurs (1989) 0.75
Rigid gas-permeable contact lenses in high and low humidity. J Am Optom Assoc (1997) 0.75
Aspheric rigid gas permeable contact lenses: practitioner discrimination of base curve increments using fluorescein pattern evaluation. Optom Vis Sci (1989) 0.75
Applying decision analysis in therapeutic drug monitoring: using decision trees to interpret serum theophylline concentrations. Clin Pharm (1986) 0.75
Design and interpretation of bioassays for carcinogenicity. Regul Toxicol Pharmacol (1987) 0.75
A new direction for the '80s: the college of pharmacy and allied health professions. Am J Hosp Pharm (1980) 0.75
A communications course in the medical technology curriculum. Am J Med Technol (1978) 0.75